Overview
Polypoidal choroidal vasculopathy is a disorder. There are currently 1 actively recruiting clinical trials.
Clinical Trials
Recent Trials
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)
Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
Initial Versus Delayed PDT Combination With Conbercept in PCV
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
Research Evidence
Peer-reviewed studies linked via MeSH term "Polypoidal Choroidal Vasculopathies" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Quick Facts
- SNOMED CT
- 1162974001
- UMLS CUI
- C1504336
- Fully Specified Name
- Polypoidal choroidal vasculopathy (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Clinical Trials
- 8
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.